INTRODUCTION
It is well established that chronic inflammation is a major driving force for tumor promotion and progression in many organs. 1 For instance, in patients with ulcerative colitis, one of the major forms of human chronic intestinal bowel disease, the risk of developing colorectal cancer is higher than in the general population. 2, 3 It has been proposed that dysregulated intestinal homeostasis, characterized by mucosal damage and microbiota translocation, contributes to colon carcinogenesis by recruiting proinflammatory immune cells (e.g., tumor-associated macrophage) into lesions, where they produce tumor-promoting cytokines that make a major contribution to colon cancer growth. 4 Recent studies have demonstrated that in the colitisassociated cancer (CAC) microenvironment, intestinal myeloid cells (predominantly dendritic cells (DCs) and macrophages) produce large amounts of interleukin-6 (IL-6) and promote tumor growth via the nuclear factor-kB-dependent signaling pathway and that the protumor effect of IL-6 is related to its ability to enhance proliferation and decrease apoptosis of preneoplastic intestinal epithelial cells (IECs). 5, 6 How this cytokine production is regulated during CAC tumorigenesis remains unclear.
The role in cancer biology of the neutrophil, the most abundant cell involved in innate immunity, has been recently highlighted. 7, 8 In tumor-bearing mice, the neutrophil is thought to be in a protumorigenic state. 9 The mechanisms responsible for this protumor activity have not yet been fully elucidated, but neutrophils have an impact on angiogenesis, immune surveillance, and the secretion of chemokines, cytokines, and reactive oxygen species. 8 During intestinal inflammation, the neutrophil has been reported to induce cell arrest and replication errors in colonic epithelial cells or to produce carcinogenic N-nitroso compounds, thus facilitating colon carcinogenesis. 10 A recent study demonstrated that neutrophils play a pathogenic role in the development of CAC, 11 but the mechanism is still largely unknown. Here we show that infiltrating neutrophils in CAC lesions abundantly produce proinflammatory cytokine IL-1b. Furthermore, we identify a protumor role of neutrophil/ IL-1b-MPs/IL-6 axis in CAC development.
RESULTS

Neutrophils infiltrate CAC lesions and contribute to CAC development
First, the involvement of neutrophil in CAC carcinogenesis was examined in both mouse experimental model and patients. The mouse model was induced in male Balb/c or TLR4 À / À mice aged 6-8 weeks by intraperitoneal injection of azoxymethane, followed by 4 cycles (84 days total) of dextran sulfate sodium (DSS) treatment, and examination on day 100.
Numerous neutrophil infiltrates were observed in lesions in the mouse model ( Figure 1a and Supplementary Figure S1 online) and in specimens from CAC patients (Supplementary Figure S2) , suggesting a tight relationship between neutrophil infiltration and CAC.
To determine the role of neutrophils in CAC tumorigenesis, we depleted this population in our mouse model using antibodies recognizing Ly-6G that is highly and specifically expressed in neutrophils, 12 with the efficacy of depletion being confirmed by fluorescence-activated cell sorting analysis (Supplementary Figure S3) . Depletion of neutrophils led to attenuation of mucosal damage and a reduced tumor load in mice with induced CAC (Figure 1b,c) and to increased Figure 1 Neutrophils infiltrate into colitis-associated cancer (CAC) lesions and contribute to tumor growth. (a) The colon tissues of mice with or without CAC were removed at days 35 and 100 respectively and fixed with formalin and then processed conventionally. Infiltrating neutrophils were identified by staining with anti-Gr-1 antibody (brown). Six pairs of mice were analyzed. Scale bar ¼ 200 mm. The cell number per field was counted in five randomly selected visual fields at original magnification Â 400. Representative results of six mice are shown on the right panel. HPF, high-power field. (b) Mice about to undergo CAC induction were injected intraperitoneally with anti-Ly6G antibody or isotype control on days À 3 and À 2 before initiation of dextran sulfate sodium (DSS) drinking (day 0), and then twice a week (days 2 and 5 each week) throughout the entire experimental period. Colon tissues were isolated on day 100 and stained with hematoxylin and eosin (H&E). Eight pairs of mice were analyzed. apoptosis of IECs ( Figure 1d ). As the antiapoptotic protein Bcl-XL (B-cell lymphoma-extra large) has been suggested to be important for IEC survival, 13 we examine its expression in IECs and found that, in neutrophil-depleted mice, IECs expressed less Bcl-XL (Figure 1e) . Furthermore, activation of nuclear factor-kB in IECs was inhibited in the neutrophil-depleted mice (Figure 1f ) that might account for the increase in IEC death. To further examine the tight association between infiltrating neutrophils and tumor growth, we prepared neutrophils from naive and CAC-bearing mice and determined their protumor function in a xenograft tumor model, and found that infusion of neutrophils from lesions of CAC-bearing mice, but not their naive counterparts, accelerated tumor growth (Figure 1g) . It is noteworthy that transferred neutrophils were alive at the intervals of observation (Supplementary Figure S4) , indicating that the neutrophil-mediated protumor effects were not secondary to the autophagy of these cells. Taken together, these findings show that, by controlling the apoptosis and proliferation of transformed IECs, infiltrating neutrophils are required for colon tumorigenesis in the CAC model.
Neutrophils that infiltrate the intestine in CAC-bearing mice are the main source of IL-1b
Although it is well established that IL-1 signaling is required for CAC development, 14, 15 the cellular source of IL-1b in the CAC microenvironment is not known. To address this issue, we measured IL-1b contents in colonic tissues and observed an increase following the establishment of CAC (Figure 2a) . To identify the cell type producing IL-1b, four subpopulations of lamina propria (LP) immune cells were prepared on the basis of Gr-1 and CD11b staining and their IL-1b mRNA levels measured. As shown in Figure 2b , the results showed that the Gr-1 hi CD11b þ cells (neutrophils) had the highest IL-1b mRNA levels before and after CAC induction and expressed much more IL-1b mRNA following establishment of CAC. Intriguingly, IL-1b mRNA expression was also detected in Gr-1 lo/ À CD11b þ cells (DCs and macrophages), although at much lower levels ( Figure 2b ). In accord with this, infiltrating neutrophils from CAC-bearing mice were found to contain more IL-1b protein than their naive littermates (Figure 2c) . Interestingly, neutrophils from the spleen of CAC-bearing mice expressed much lower amounts of IL-1b mRNA that were comparable to those in controls ( Figure 2d ). These findings indicate that the intestinal inflammatory milieu elicits high IL-1b expression in infiltrating neutrophils and that this is critical for CAC development.
In vivo blockade of IL-1b activity in mice reduces CAC carcinogenesis
To determine whether IL-1b was involved in CAC development, we used the IL-1 receptor antagonist (IL-1Ra) to block IL-1b bioactivity in the mice. Furthermore, to investigate the effect of IL-1b on premalignant neoplasia growth and late-stage tumor progression, two schedules of IL-1Ra injection were used: in the first, IL-1Ra was injected during four cycles of DSS administration, whereas, in the second, it was injected only after the last DSS cycle (Figure 3a) .
Using the first schedule, the number of tumor nodules in the colon of mice treated with IL-1Ra was significantly decreased (Figure 3b) , mucosal injury and inflammatory infiltrates decreased (Figure 3c ), and apoptosis of IECs increased ( Figure 3d) . Furthermore, nuclear factor-kB activation in IECs was reduced considerably in IL-1Ra-treated mice ( Figure 3e ). Using the second schedule (end-stage disease), IL-1Ra treatment resulted in a significant decrease in frequency and size of colon tumors in mice harboring established CAC (Supplementary Figure S5A and B). This effect may be attributed to reduced proliferation as well as increased apoptosis of IECs (Supplementary Figure S5C and D). Overall, these findings indicate an important role of neutrophil-derived IL-1b in CAC promotion and progression.
IL-1b induces IL-6 production by intestinal mononuclear phagocytes (MPs) To dissect the mechanisms underlying the protumor function of IL-1b, we hypothesized that the effect of IL-1b might be mediated by IL-6, a putative CAC-promoting factor, as IL-1b is known to be a strong inducer of IL-6 production in several cell types. 16 As expected, IL-6 protein levels in the affected colon of CAC-bearing mice were dramatically increased compared with those in naive mice (Supplementary Figure S6A) . Dissection of the cell types responsible for secreting IL-6 in CAC milieus showed that IL-6 mRNA was expressed almost exclusively in DCs and macrophages, i.e., in intestinal MPs (Supplementary Figure S6B) . Moreover, IL-6 mRNA expression was considerably higher in DCs than in macrophages, in agreement with a previous study. 5 To determine whether IL-6 acted downstream of IL-1 signaling, we isolated Gr-1 lo/ À CD11b þ immune cells from the LP of mice with or without IL-1Ra treatment during the DSS cycles for CAC induction ( Figure 3a) . As shown in Figure 4a , IL-1Ra injection led to a significant reduction in IL-6 mRNA expression by CD11b þ MPs, showing that IL-1 signaling was needed for IL-6 production by intestine-resident immune cells during CAC induction in vivo. To evaluate a direct effect of IL1b on IL-6 production, intestinal CD11b þ MPs were prepared from naive mice and stimulated by IL-1b, and the results showed that IL-1b stimulation alone was sufficient to elicit the synthesis of IL-6 mRNA ( Figure 4b) and protein (Figure 4c) . Furthermore, in coculture experiments, neutrophils isolated from the LP of CAC-bearing mice, but not naive mice, were able to induce IL-6 production in CD11b þ MPs (Figure 4d ) and this effect was prevented by addition of IL-1Ra to the medium. These results suggest that infiltrating neutrophils produce a high level of IL-1b that then induces LP-resident DCs/ macrophages to express IL-6.
Commensal flora translocation is required for IL-1b production by infiltrated neutrophils In our mouse model, commensal microbiota translocation following injury to the epithelial barrier induced by DSS instillation is a key event in triggering intestinal inflammation. 17 We therefore speculated that invasion by the luminal microflora was necessary for neutrophil infiltration and their increased expression of IL-1b. To address this, commensal microorganisms were eradicated by antibiotics and inflammatory infiltrates were examined in the control and antibiotictreated CAC mice and the results showed that antibiotics administration profoundly reduced neutrophil infiltration (Figure 5a) . Furthermore, the ability of gut neutrophils to produce IL-1b was significantly impaired (Figure 5b) . These findings suggest that the signaling triggered by commensal flora-derived ligands is important for IL-1b expression by infiltrating neutrophils. Furthermore, using Toll-like receptor 4 (TLR4)-knockout mice that are protected against CAC as previously reported, 18 we showed that the absence of TLR4-mediated signaling also led to a considerable reduction in IL-1b production by infiltrating neutrophils (Figure 6c) . We also isolated neutrophils from the spleen of naive mice and stimulated these cells with the TLR4 ligand lipopolysaccharide (LPS), and found that LPS induced IL-1b expression (Figure 6d ). Overall, these findings indicate a crucial role of commensal flora-derived LPS-mediated signaling in promoting IL-1b expression in infiltrating neutrophils during CAC carcinogenesis.
The IL-1/IL-6 cascade is involved in development of ulcerative colitis-associated cancer
To examine whether the results in mice applied to human disease, colon specimens were collected from patients with ulcerative colitis-associated cancer. Immunofluorescence staining for neutrophils (human neutrophil peptides 1-3) and IL-1b showed marked accumulation of IL-1b-expressing neutrophils in the inflamed colon tissues of ulcerative colitisassociated cancer patients (Figure 6a) . Moreover, fluorescenceactivated cell-sorted infiltrating neutrophils (CD66b þ ) from CAC lesions contained much higher levels of IL-1b mRNA than those from the peripheral blood of healthy volunteers (Figure 6b ). In addition, CD68
þ MPs in intestinal lesions produced large amounts of IL-6 protein ( Figure 6c ) and mRNA ( Figure 6d) . To test the ability of IL-1b-expressing neutrophils to induce IL-6 production in DCs/macrophages, we isolated neutrophils from colon tissues of patients with CAC or the peripheral blood of healthy volunteers and cocultured them with intestinal CD11b þ MPs from the healthy colon adjacent to the tumor and found that CAC-derived neutrophils induced the control MPs to produce IL-6 protein and that this effect was IL-1b dependent, as it was prevented by addition of the IL-1Ra (Figure 6e ). In addition, direct IL-1b stimulation was sufficient to induce IL-6 mRNA expression in LP-derived MPs from healthy colon (Figure 6f) , indicating a key function of neutrophil-derived IL-1b in the induction of IL-6 expression in intestinal MPs. Furthermore, LPS challenge was able to drive control neutrophils to produce IL-1b mRNA (Supplementary Figure S7) .
DISCUSSION
The results of our study provide support for a protumor function of infiltrated neutrophils in carcinogenesis in inflammation-associated colon cancer, although their role in tumor development is still controversial. [19] [20] [21] To examine this issue, Fridlender et al. 9 recently proposed that, like tumorassociated macrophages, tumor-associated neutrophils can be classified into two subpopulations with an antitumor (N1) or protumorigenic phenotype (N2), differentiation of which is dependent on the tumor microenvironment. Given the tumorpromoting function of neutrophils infiltrating colon tissues of CAC-bearing mice and patients seen in our study, they can be classified as N2 tumor-associated neutrophil.
IL-1 signaling has been shown to play a critical role in gut homeostasis, intestinal inflammation, and colitis-associated tumorigenesis, 14 but the cellular source of IL-1b, an important member of the IL-1 family, has not been determined. Herein, we provide evidence that, in colonic inflammation, IL-1b is predominantly produced by infiltrated neutrophils. Interestingly, a previous study demonstrated that, in the steady state, intestinal macrophages constitutively express IL-1b that is pivotal for T helper type 17 cell differentiation in the intestine. 22 These findings indicate that the pattern of IL-1b expression in intestinal tissues is regulated by the local microenvironment. It is noteworthy that in our study, a relatively high level of IL-1b mRNA expression was observed in neutrophils in naive mice, but not in CD11b þ phagocytes (Figure 2b) . This difference can be explained if, in the homeostatic state, the frequency of neutrophils in the intestine is much lower than that of macrophages and that, upon initiation of colitis, a large number of neutrophils move into the mucosa and release substantial amounts of IL-1b in response to proinflammatory stimuli, similar to a model of LPS-induced shock. 23 The commensal flora may be an important inducer for IL-1b, as, in our study, antibiotic treatment or TLR4 deficiency led to a significant reduction in IL-1b expression by the infiltrated neutrophils. It should be noted that we did not found substantial expression of IL-1b in spleen neutrophils from CAC-bearing mice, indicating that luminal bacteria translocation is necessary for IL-1b expression by infiltrated neutrophils. In addition, it is noteworthy that although depletion of neutrophil or blockade of IL-1 activity actively repressed CAC formation, these treatments did not completely eradicate the tumors. These data suggest that IL-1b-producing neutrophil is a key player in the pathogenesis of CAC, and other components such as IL-21, tumor necrosis factor, and vascular endothelial growth factor also contribute to CAC development, as shown by previous ) and then IL-6 protein levels were measured by enzyme-linked immunosorbent assay (ELISA). The data are pooled from three independent experiments. (f) MPs were isolated from the LP of the normal mucosa of patients with CAC and incubated for 24 h with or without (unstimulated (US)) IL-1b (1 mg ml À 1 ), and then IL-6 expression was measured by quantitative RT-PCR. The data are pooled from three independent experiments. **Po0.01; ***Po0.001.
reports. [24] [25] [26] Therefore, it is plausible that several pathways including neutrophil/IL-1b/IL-6 axis synergistically orchestrate to promote CAC formation.
It is well established that the inflammasome, a multiprotein complex formed by NOD-like receptor (NLR) family members, converts inactive procaspase-1 to active caspase-1 that cleaves the inactive IL-1 in precursor to a secreted and active cytokine. 27 Intriguingly, mice deficient in inflammasome NLRP3 or caspase-1 have been found to be more susceptible to colitis and CAC. 28, 29 Although it is well established that components of the inflammasome function to process pro-IL1b and IL-18 into mature cytokines, the phenotype of NLRP3 À / À mice with more severe colitis appears not to be attributed to reduced levels of proinflammatory mediators IL-1b, given that deficiency in a negative regulator for IL-1R signaling renders mice more susceptible to colitis and cancer induction, 14, 15 which is consistent with the conclusions drawn in our study. One possible explanation of enhanced inflammatory reaction in NLRP3 À / À mice can be attributed to reduced IL-18 levels. 30, 31 Furthermore, exogenous IL-18 injection resulted in less weight loss in DSS-instilled caspase-1 À / À mice. 30 Thus, NLRP3 inflammasome signaling through IL-18 confers protection against DSS-induced colitis. An alternative explanation is that increased susceptibility of NLRP3 À / À mice to colitis may be caused by a role of NLRP3-caspase 1-mediated signaling in enhancing programmed cell death. 32 Specifically, NLRP3-caspase 1-mediated signaling is proapoptotic in infiltrating immune cells during colitis and its deficiency may lead to reduced apoptosis of these cells, and thereby more severe colitis. In addition, it is noteworthy that, in contrast to the conclusions as shown by studies above, Bauer et al. 33 demonstrated that NLRP3 inflammasome signaling played a pathogenic role during colitis and NLRP3 deficiency conferred protection against mucosal damage during intestinal inflammation. Therefore, further investigations in the roles of inflammasomes in intestinal inflammation are warranted.
With respect to the actions of IL-1b, in this study, we show that IL-6 is an important link between IL-1b and CAC formation and that neutrophil-derived IL-1b is a critical inducer of IL-6 production by intestinal MPs. The CACpromoting effect of IL-6 has been proposed to be because of its ability to enhance the proliferation of IECs in an inflammatory situation and protect them against apoptosis through the signal transducer and activator of transcription 3-mediated signaling pathway. 5, 6 Therefore, we believe that infiltrating neutrophils produce large amounts of IL-1b in response to flora stimuli and the IL-1b then enhances IL-6 production in intestine-resident MPs, thereby promoting CAC transformation and growth. The crucial role of IL-1b in intestine homeostasis as a housekeeper that can distinguish harmful from nonpathogenic microorganisms in the gut has been recently highlighted. 34 Taken together, these findings strongly support a key role of IL-1b in regulating intestinal immunity not only in the homeostatic state, but also in pathogenic states.
In the inflammatory situation, neutrophil recruitment into the intestine is regulated by a series of cytokines and chemokines. 35 We have previously demonstrated the expression of several factors in the mucosa and found that, during DSS-induced colitis, there is a significant increase in the expression of several chemokines, 36 including CXCL2, that have well established roles in recruiting peripheral neutrophils into tumor sites. 37 Intriguingly, IL-1b has an indirect role in recruiting granulocytes. 38 In fact, blockade of IL-1b activity in our study led to a significant reduction in neutrophils in the colon mucosa, indicating a positive feedback of IL-1b on the recruitment of more neutrophils into colonic tissues, thereby exacerbating the inflammatory response. Overall, our study provides a mechanistic explanation of how neutrophils are involved in the development of inflammation-related colorectal cancer. Neutrophil-targeted therapy or blockade of IL-1b bioactivity using specific antagonists may be beneficial for the treatment of CAC in the clinic.
METHODS
Mice. Balb/c, TLR4 À / À , and nude mice were purchased from Jackson Laboratory (Bar Harbor, ME) and housed in specific pathogenfree conditions on an alternating light/dark cycle. TLR4 À / À Balb/c mice were obtained by backcross for 12 generations onto the Balb/c background; in this study, all references to 'TLR4 À / À ' or 'TLR4 knockout' mice refer to these backcrossed mice. All animal experiments were performed in accordance with international guidelines for the care and use of laboratory animals and approved by the Animal Ethics Committee of the Institute of Basic Medical Sciences.
Patients. Freshly isolated neoplastic tissue samples and adjacent normal mucosa were obtained from patients undergoing surgical resection with the diagnosis of CAC (n ¼ 18). No chemotherapy or radiotherapy was performed before collection of the tissue samples. The samples were sectioned for immunohistochemistry and hematoxylin and eosin staining and for the isolation of LP immune cells. Prior informed consent was obtained and the study protocol was approved by the Ethics Committee of the General Hospital of the PLA (Beijing, China).
CAC model. CAC was induced as described previously, 39 with slight modifications. Male Balb/c or TLR4 À / À mice aged 6-8 weeks were injected once intraperitoneally with azoxymethane (10 mg kg À 1 ; Sigma-Aldrich, St Louis, MO) and maintained on regular diet and water for 5 days. They then underwent the first DSS treatment cycle in which they received drinking water containing 2% DSS (molecular weight 36,000-50,000; MP Biochemicals, Solon, OH) for 1 week, starting on day 0, then plain water for 2 weeks (1 cycle), and this was followed by three more DSS treatment cycles (84 days total). They were then maintained on a regular diet with normal drinking water until day 100, when they were killed and macroscopic tumors counted. The clinical course of the disease was followed daily by measurement of body weight and monitoring for signs of rectal bleeding or diarrhea.
Histopathology and immunohistochemistry. The protocol on histopathology and immunohistochemistry is described in Supplementary Materials and Methods.
Immunoblotting. Standard procedures for immunoblotting are described in Supplementary Materials and Methods.
Mouse whole colon cultures. The experiments were done as described in Supplementary Materials and Methods.
Detection and quantification of apoptotic cells. Experiments were carried out as described in Supplementary Materials and Methods.
In vivo antibody or antagonist treatment. Experiments were performed as described in Supplementary Materials and Methods.
Isolation of mouse and human colonic epithelial cells. Colonic epithelial cells were fractionated as described previously 40 with light modification. The details are described in Supplementary Materials and Methods.
Isolation of mouse spleen cells, mouse and human LP immune cells, human blood neutrophils, and in vitro treatment. The protocol is described in Supplementary Materials and Methods.
Flow cytometry. The experiments were done as described in Supplementary Materials and Methods.
Commensal flora depletion. The protocol of depletion of Commensal microbiota was detailed in Supplementary Materials and Methods. The efficacy of commensal depletion by the antibiotics was confirmed by staining with SYBR green solution (TOYOBO, Osaka, Japan) as described previously. 14 Tumor transplantation. Experiments were performed as described in Supplementary Materials and Methods.
Cytokine assays. IL-6 and IL-1b levels in culture supernatants were measured using enzyme-linked immunosorbent assay kits (R&D Systems, Minneapolis, MN) according to the manufacturer's instructions.
Quantitative reverse-transcriptase-polymerase chain reaction.
Experiments were carried out as described in Supplementary Materials and Methods.
